Influence of melatonin on cell proliferation, antioxidative enzyme activities and lipid peroxidation in 3T3-L1 preadipocytes - An in vitro study

Journal of Physiology and Pharmacology

Volumn 56, Issue SUPPL. 6, 2005, Pages 91-99

  Zwirska Korczala, K ^a,b   Jochem, J ^a   Adamczyk Sowa, M ^a   Sowa, P ^a   Polaniak, R ^a   Birkner, E ^a   Latocha, M ^b   Pilc, K ^a   Suchanek, R ^a  

^a Department of Physiology ^*  (Poland)

^b MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

3T3 L1 preadipocytes; Antioxidative enzyme activities; Cell proliferation; Luzindole; Malondialdehyde; Melatonin

Indexed keywords

CATALASE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; LUZINDOLE; MALONALDEHYDE; MELATONIN; SUPEROXIDE DISMUTASE;

ANIMAL CELL; CELL PROLIFERATION; CELL STIMULATION; CONFERENCE PAPER; CONTROLLED STUDY; ENZYME ACTIVITY; LIPID PEROXIDATION; LIPOLYSIS; NONHUMAN; PROADIPOCYTE; RECEPTOR BINDING;

3T3-L1 CELLS; ADIPOCYTES; ANIMALS; ANTIOXIDANTS; CELL PROLIFERATION; DOSE-RESPONSE RELATIONSHIP, DRUG; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; LIPID PEROXIDATION; MALONDIALDEHYDE; MELATONIN; MICE; RECEPTOR, MELATONIN, MT1; RECEPTOR, MELATONIN, MT2; RECEPTORS, MELATONIN; SUPEROXIDE DISMUTASE; TIME FACTORS;

EID: 31044449957     PISSN: 08675910     EISSN: 08675910     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (38)

1. Rehfeld JF, Bundgaard JR, Friis-Hansen L, Goetze JP. On the tissue specific processing of procholecystokinin in the brain and gut - a short review. J Physiol Pharmacol 2003; 54: 73-79.
2. Peeters TL. Central and peripheral mechanisms by which ghrelin regulates gut motility. J Physiol Pharmacol 2003; 54: 95-103.
3. Chey WY, Chang T. Neural control of the release and action of secretin. J Physiol Pharmacol 2003; 54: 105-112.
4. Reiter RJ, Tan D, Mayo JC, Sainz RM, Leon J, Bandyopadhyay D. Neurally-mediated and neurally-independent beneficial actions of melatonin in the gastrointestinal tract. J Physiol Pharmacol 2003; 54: 113-125.
5. Beyer CE, Steketee JD, Saphier D. Antioxidant properties of melatonin - an emerging mystery. Biochem Pharmacol 1998; 56: 1265-1272.
6. Prunet-Marcassus B, Ambid L, Viguerie-Bascands N, Penicaud L, Casteilla L. Evidence for a direct effect of melatonin on mitochondrial genome expression of Siberian hamster brown adipocytes. J Pineal Res 2001, 30: 108-115.
7. Bartness TJ, Demas GE, Song CK. Seasonal changes in adiposity: the roles of the photoperiod, melatonin and other hormones, and sympathetic nervous system. Exp Biol Med 2002, 227: 363-376.
8. Brydon L, Petit L, Delagrange P, Strosberg AD, Jockers R. Functional expression of MT2 (Mel1b) melatonin receptors in human PAZ6 adipocytes. Endocrinology 2000; 142: 4264-4271.
9. Kopecky J, Rossmeisl M, Flachs P, et al. Energy metabolism of adipose tissue - physiological aspects and target in obesity treatment. Physiol Res 2004: S225-232.
10. Sainz RM, Mayo JC, Rodriguez C, Tan DX, Lopez-Burillo S, Reiter RJ. Melatonin and cell death: differential actions on apoptosis in normal and cancer cells. Cell Mol Life Sci 2003; 60: 1407-1426.
11. Blask DE, Sauer LA, Dauchy RT, Holowachuk EW, Ruhoff MS, Kopff HS. Melatonin inhibition of cancer growth in vivo involves suppression of tumor fatty acid metabolism via melatonin receptor-mediated signal transduction events. Cancer Res 1999; 59: 4693-4701.
12. Roth JA, Rosenblatt T, Lis A, Bucelli R. Melatonin-induced suppression of PC12 cell growth is mediated by its Gi coupled transmembrane receptors. Brain Res 2001; 16: 919:139-46.
13. Drazen DL, Bilu D, Bilbo SD, Nelson RJ Melatonin enhancement of splenocyte proliferation is attenuated by luzindole, a melatonin receptor antagonist. Am J Physiol Regul Integr Comp Physiol 2001; 280: 1476-1482.
14. Nakade O, Koyama H, Ariji H, Yajima A, Kaku T. Melatonin stimulates proliferation and type I collagen synthesis in human bone cells in vitro. J Pineal Res 1999; 27: 106-110.
15. Reiter JR. Melatonin: lowering the high price of free radicals. News Physiol Sci 2000; 15: 246-250
16. Baydas G, Gursu MF, Yilmaz S, et al. Daily rhythm of glutathione peroxidase activity, lipid peroxidation and glutathione levels in tissue of pinealectomized rats. Neurosci Lett 2002; 323: 195-198.
17. Rodriguez C, Mayo JC, Sainz RM, et al. Regulation of antioxidant enzymes: a significant role for melatonin. J Pineal Res 2004; 36:1-9.
18. Dubocovich ML. Luzindole (N-0774): a novel melatonin receptor antagonist. J Pharmacol Exp Ther 1988; 246: 902-910.
19. Alvarez M. 3T3 cells in adipocytic conversion. Arch Invest Med (Mex) 1991; 22: 235-241.
20. Oyanagui Y. Reevaluation of assay methods and establishment of kit for superoxide dismutase activity. Anal Biochem 1984; 142: 290-296.
21. Zwirska-Korczala K, Jochem J, Rybus-Kalinowska B, Polaniak R, Birkner E. Assessment of blood superoxide dismutase and glutathione peroxidase activities, and malondialdehyde concentration as oxidation status parameters in obese women. Pol Arch Med Wewn 2003; 110: 725-731.
22. Paglia DE, Valentine WN. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 1967; 70: 158-169.
23. Aebi H. Catalase in vitro. Methods Enzymol 1984; 105: 121-126.
24. Carlberg I, Mannervik B. Glutathione reductase. Methods Enzymol. 1985; 113: 484-490.
25. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979; 95: 351-358.
26. Sainz RM, Mayo JC, Kotler M, Uria H, Antolin I, Rodriguez C. Melatonin decreases mRNA for histone H4 in thymus of young rats. Life Science 1998; 63: 1109-1117.
27. Baydas G, Ercel E, Canatan H, Donder E, Akyol A. Effect of melatonin on oxidative status of rat brain, liver and kidney tissues under constant light exposure. Cell Biochem Funct 2001; 19: 37-41.
28. Jochem J. Involvement of the renin-angiotensin system in endogenous central histamine-induced reversal of critical haemorrhagic hypotension in rats. J Physiol Pharmacol 2004; 55: 39-55.
29. Jochem J, Zwirska-Korczala K, Gwozdz B, Walichiewicz P, Josko J. Cardiac and regional haemodynamic effects of endothelin-1 in rats subjected to critical haemorrhagic hypotension. J Physiol Pharmacol 2003; 54: 383-396.
30. Jajte J, Zmyslony M. The role of melatonin in the molecular mechanism of weak, static and extremely low frequency (50 Hz) magnetic fields (ELF). Med Pr 2000; 51: 51-57.
31. Ross SM. Combinated DC and ELF magnetic fields can alter cell proliferation. Bioelectromagnetics 1990; 11: 27-36.
32. Zwirska-Korczala K, Adamczyk-Sowa M, Polaniak R, et al. Influence of extremely-low-frequency magnetic field on antioxidative melatonin properties in AT478 murine squamous cell carcinoma culture. Biol Trace Elem Res 2004; 102: 227-243.
33. Jaworek J, Konturek SJ, Leja-Szpak A, et al. Role of endogenous melatonin and its MT2 receptor in the modulation of caerulein-induced pancreatitis in the rat. J Physiol Pharmacol 2002; 53: 791-804.
34. Mayo JC, Sainz RM, Antoli I, Herrera F, Martin V, Rodniguez C. Melatonin regulation of antioxidant gene expression. Cell Mol Life Sci 2002; 59: 1706-1713.
35. Tunez I, Munoz MC, Feijoo M, et al. Protective melatonin effect on oxidative stress induced by okadaic acid into rat brain. J Pineal Res 2003; 34: 265-268.
36. Kilańczyk E, Bryszewska M. The effect of melatonin on antioxidant enzymes in human diabetic skin fibroblasts. Cell Mol Biol Lett 2003; 8: 333-336.
37. Dziegiel P, Murawska-Cialowicz E, Jethon Z, et al. Melatonin stimulates the activity of protective antioxidative enzymes in myocardial cells of rats in the course of doxorubicin intoxication. J Pineal Res 2003; 35: 183-187.
38. Mayo JC, Tan DX, Sainz RM, Lopez-Burillo S, Reiter RJ. Oxidative damage to catalase induced by peroxyl radicals: functional protection by melatonin and other antioxidants. Free Radic Res 2003; 37: 543-553.